Please login to the form below

Not currently logged in
Email:
Password:

LaingBuisson names chairman and CEO

Former Health Secretary Stephen Dorrell and Henry Elphick join

LaingBuisson Stephen DorrellLaingBuisson, a UK healthcare market intelligence provider, has named Stephen Dorrell and Henry Elphick as its chairman and chief executive officer, respectively.

Stephen Dorrell (pictured right) served as an MP for 36 years and during that time worked as a minister in the Treasury, the Department of National Heritage, and the Department of Health.

Between 1995 and 1997, Dorrell was the Secretary of State for Health, and became the first elected chair of the House of Commons Health Committee in 2010.

He currently serves as chair of the NHS Confederation and is a senior advisor to KPMG on global health and public sector practice.

Meanwhile, Henry Elphick (pictured below) brings 19 years of investment banking experience to the firm, joining from Jeffries International where he most recently served as European joint head of healthcare investment banking.

LaingBuisson Henry ElphickPrior to this Elphick held management roles at Rothschild and UBS, as well as working as a lawyer with Linklaters in its London, New York and Washington offices.

Elphick said: “LaingBuisson is already a trusted advisor to its clients and plays a major role in the UK's healthcare sector as the definitive source of market information and data.

“With the appointment of Stephen as chairman and myself as chief executive officer, our immediate focus will be to continue acting as close advisors to our clients.

“However, in these changeable times, we believe there is further potential for adapting and broadening our offering of products and services to help our clients better understand the complex challenges and opportunities of the market today.

“We are looking forward to working with William Laing as an ongoing director, the rest of the board and the team at LaingBuisson.”

4th July 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...